Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,090 | 247 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $729.47 | 41 | $0 (2024) |
| ABBVIE INC. | $556.75 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $523.57 | 34 | $0 (2024) |
| Amgen Inc. | $225.85 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $204.00 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $176.84 | 12 | $0 (2024) |
| Abbott Laboratories | $172.04 | 10 | $0 (2024) |
| Merck Sharp & Dohme LLC | $154.07 | 9 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $146.94 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $146.04 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,282 | 74 | Lilly USA, LLC ($246.13) |
| 2023 | $1,799 | 109 | Lilly USA, LLC ($363.98) |
| 2022 | $946.18 | 60 | ABBVIE INC. ($119.58) |
| 2021 | $62.75 | 4 | AbbVie Inc. ($62.75) |
All Payment Transactions
247 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Biological | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Diabetes Care | ||||||
| 11/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Inflammation | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Biological | ||||||
| 09/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Endocrinology | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: PAIN | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: DIABETES | ||||||
| 07/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Endocrinology | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 35 | 40 | $704.00 | $107.36 |
| 2022 | 1 | 27 | 31 | $558.00 | $68.73 |
| 2021 | 1 | 18 | 23 | $414.00 | $51.75 |
| 2020 | 1 | 12 | 13 | $234.00 | $29.15 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 16 | $272.00 | $54.56 | 20.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 21 | 24 | $432.00 | $52.80 | 12.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 27 | 31 | $558.00 | $68.73 | 12.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 18 | 23 | $414.00 | $51.75 | 12.5% |
| 81003 | Automated urinalysis test | Office | 2020 | 12 | 13 | $234.00 | $29.15 | 12.5% |
About Amanda Sailliez, PAC
Amanda Sailliez, PAC is a Physician Assistant healthcare provider based in Murphysboro, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255305967.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Sailliez, PAC has received a total of $4,090 in payments from pharmaceutical and medical device companies, with $1,282 received in 2024. These payments were reported across 247 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($4,090).
As a Medicare-enrolled provider, Sailliez has provided services to 92 Medicare beneficiaries, totaling 107 services with total Medicare billing of $256.99. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Murphysboro, IL
- Active Since 02/17/2006
- Last Updated 05/15/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1255305967
Products in Payments
- MOUNJARO (Drug) $489.62
- BREZTRI (Drug) $262.68
- VRAYLAR (Drug) $228.70
- FARXIGA (Drug) $217.75
- Otezla (Drug) $210.34
- TRADJENTA (Drug) $188.78
- ZENPEP (Drug) $164.37
- LEQVIO (Drug) $146.94
- TRELEGY ELLIPTA (Drug) $146.41
- GEMTESA (Drug) $139.18
- UBRELVY (Drug) $136.48
- QULIPTA (Drug) $126.95
- Kerendia (Drug) $120.63
- NURTEC ODT (Drug) $96.85
- Veozah (Drug) $92.08
- FREESTYLE LIBRE 2 (Device) $85.12
- INGREZZA (Drug) $83.76
- EMGALITY (Drug) $81.26
- BELSOMRA (Drug) $78.45
- Ozempic (Drug) $70.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.